Summary

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.67 for the 2022 fiscal year.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the past twelve months, EPS forecast has been revised upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Analyst opinion has improved significantly over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● The company has insufficient levels of profitability.

● Most analysts recommend that the stock should be sold or reduced.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● The group usually releases earnings worse than estimated.